Afrin
- Product NDC
- 67751-185
- 11-digit product format
- 677510185
- Labeler code
- 67751
- Product ID
- 67751-185_2385f57c-492c-9e37-e063-6394a90ad69d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- OXYMETAZOLINE HYDROCHLORIDE
- Dosage form
- SPRAY
- Route
- TOPICAL
- Labeler
- Navajo Manufacturing Company Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2017-12-04
- Substance
- OXYMETAZOLINE HYDROCHLORIDE
- Active strength
- .05 g/100mL
- Pharmacologic classes
- Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Afrin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OXYMETAZOLINE HYDROCHLORIDE | .05 g/100mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| K89MJ0S5VY | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 65bf1556-f234-9439-e053-2a91aa0a3194 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| e67be450-f8e4-4bc1-88bd-1259d379f55f | Product name | 1 | 20210127 |
| c53f3286-4062-4cf5-8355-399519c639a6 | Product name | 1 | 20170424 |
| a993dfc5-f219-4460-bde6-30dd724d9ef0 | Product name | 1 | 20160818 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67751-185-01 | 2023-03-15 | C162847 | 48780-1 | f386c649-ebc6-0266-e053-dadaa90a7c1a | Afrin |
| 67751-185-01 | 2023-01-30 | C162847 | 48780-1 | f386c649-ebc6-0266-e053-dadaa90a7c1a | Afrin |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67751-185-01 | Afrin | 15 mL in 1 BOTTLE, SPRAY | SPRAY | 15 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold and Allergy | PHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE | Allegiant Health | 7af63769-fa56-4f1f-a2ad-5b4c108c8e4f | 2019-12-12 | Warnings | M012 |
| Mucus Relief Immediate Release | GUAIFENESIN | Allegiant Health | 221d64a2-b8c7-435a-aae4-fb58fd38108f | 2019-03-26 | Warnings | M012 |
| Sleep Tabs For Nighttime use | DIPHENHYDRAMINE HCL TABLETS | Allegiant Health | 566e40b1-e9d7-44e4-b971-eef2b7cf0a7d | 2018-12-26 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Allegiant Health | 4305ad50-d2a5-4d3e-9d92-cbf26e856a16 | 2018-12-26 | Warnings | M012 |
| Sleep Aid | DIPHENHYDRAMINE HCL 25 MG | Allegiant Health | dbbc535f-515a-4d9b-b799-34e60f5230bb | 2018-12-21 | Warnings | M012 |
| Allergy | DIPHENHYDRAMINE HCL | Allegiant Health | c2823bad-540f-4662-8dcc-58e9f0d94efb | 2018-11-07 | Warnings | M012 |
| Nasal Decongestant PE Maximum Strength Non-Drowsy | PHENYLEPHRINE 10 MG | Allegiant Health | 7aef00df-816a-4ea2-a2ad-beed66dd2fe4 | 2018-11-07 | Warnings | M012 |
| DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a58bfb14-28f9-4425-a5a5-aaff4847c979 | 2018-03-14 | Warnings | M012 |
| Chlorpheniramine maleate 4mg | CHLORPHENIRAMINE MALEATE 4MG | Athlete's Needs, Inc. | 4d974959-25fc-4707-9b72-9afbf47b76f1 | 2017-11-14 | Warnings | M012 |
| Cold Medicine | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Selder, S.A. de C.V. | d2762d9c-e7e7-42b2-a26a-14b2aa0307cb | 2017-01-25 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Marc Glassman, Inc. | 2051247f-ce64-4cf5-b449-9ca14c43ab86 | 2016-12-27 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1000992 | Afrin 0.05 % Nasal Spray | PSN | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000990 | oxymetazoline HCl 0.05 % Nasal Spray | PSN | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000992 | oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Afrin] | SBD | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000990 | oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000992 | Afrin 0.05 % Nasal Spray | SY | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000992 | Afrin 0.5 MG/ML Nasal Spray | SY | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000990 | oxymetazoline hydrochloride 0.05 % Nasal Spray | SY | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67751-185-01 | 67751018501 | 15 mL in 1 BOTTLE, SPRAY (67751-185-01) | 15 ml | 2017-12-04 | 0000-00-00 | No | No | Current |